Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

16

Number of overlapping holdings

18.0%

% of WDNA's 91 holdings also in XDNA

69.6%

% of XDNA's 23 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus XDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in XDNA
Overlap
CRISPR THERAPEUTICS AG 1.9% 15.1% 1.9%
CARIBOU BIOSCIENCES, INC. 1.5% 4.7% 1.5%
VERTEX PHARMACEUTICALS INC 1.3% 1.5% 1.3%
BEAM THERAPEUTICS, INC. 1.3% 13.7% 1.3%
REGENERON PHARMACEUTICALS 1.3% 1.3% 1.3%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to XDNA
IOVANCE BIOTHERAPEUTICS INC 3.8%
TWIST BIOSCIENCE CORP. 3.4%
FATE THERAPEUTICS INC 2.8%
NOVOZYMES A/S-B SHARES 2.4%
BLUEPRINT MEDICINES CORP. 2.1%
BRIDGEBIO PHARMA, INC. 2.0%
ELI LILLY & CO 2.0%
VERICEL CORPORATION 1.8%
AGIOS PHARMACEUTICALS INC 1.7%
ALCOBRA LTD 1.6%
WDNA Underweight Relative to XDNA
CRISPR THERAPEUTICS AG -13.3%
BEAM THERAPEUTICS, INC. -12.4%
THERMO FISHER SCIENTIFIC INC -8.4%
INTELLIA THERAPEUTICS, INC. -7.9%
PRIME MEDICINE, INC. -5.9%
EDITAS MEDICINE, INC. -4.5%
POSEIDA THERAPEUTICS, INC. -4.1%
ABBVIE INC -3.8%
VERVE THERAPEUTICS, INC. -3.4%
SANOFI-AVENTIS -3.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY